文献速递慢性肾脏病血液净化与透析

2型糖尿病合并CKD患者心衰、心梗或卒中后ESRD风险

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.
PubMed 文献 · Am J Kidney Dis · 2017-06-07

本研究基于TREAT试验的4022例2型糖尿病合并贫血和CKD患者,观察随机化后心血管事件对ESRD进展的影响。结果显示,652例ESRD中155例(23.8%)发生在心血管事件后,其中心衰后110例(16.9%);有心血管事件者30天内ESRD风险显著增高(HR 22.2),其中心衰后风险最高。

要点

  • 心衰后ESRD风险显著高于心梗或卒中后
  • 心血管事件后30天内ESRD风险急剧升高
  • ESRD后死亡率在有和无心血管事件者中相似

核心结论

  • 多数ESRD发生在无心血管事件但基线eGFR更低的患者中,但有心血管事件者ESRD风险显著增高,尤以心衰后为著。

研究设计与样本

  • 观察性研究,纳入TREAT试验中4022例2型糖尿病合并贫血和CKD患者,分析随机化后心血管事件与ESRD的关系。

主要发现

  • 652例ESRD中155例(23.8%)发生在心血管事件后,其中心衰后110例(16.9%)、心梗后28例(4.3%)、卒中后12例(1.84%)、多发事件后5例(0.77%)。
  • 有心血管事件者30天内ESRD发生率更高(HR 22.2,95%CI 17.0-29.0)。
  • 心衰后ESRD总体风险(HR 3.4,95%CI 2.7-4.2)及30天风险(HR 20.1,95%CI 14.5-27.9)均高于心梗或卒中后(P<0.001)。
  • 发生心血管事件后ESRD者较无事件ESRD者更年长、既往心血管病比例更高,基线eGFR更高(24.4 vs 23.1 mL/min/1.73m2,P=0.01),末次eGFR也更高(18.6 vs 15.2 mL/min/1.73m2,P<0.001)。
  • ESRD后死亡率在有和无心血管事件者中相似(P=0.3)。

临床怎么用

  • 对2型糖尿病合并CKD患者,发生心衰等心血管事件后应密切监测肾功能,警惕短期内ESRD风险。

局限性

  • 研究人群限于临床试验中合并糖尿病和贫血的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: How cardiovascular (CV) events affect progression to end-stage renal disease (ESRD), particularly in the setting of type 2 diabetes, remains uncertain. STUDY DESIGN: Observational study. SETTING & PARTICIPANTS: 4,022 patients with type 2 diabetes, anemia, and chronic kidney disease from the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). PREDICTOR: Postrandomization CV events. OUTCOMES: ESRD (defined as initiation of dialysis for >30 days, kidney transplantation, or refusal or nonavailability of renal replacement therapy) and post-ESRD mortality within 30 days and during overall follow-up after an intercurrent CV event. LIMITATIONS: Population limited to clinical trial participants with diabetes and anemia. RESULTS: 155 of 652 (23.8%) ESRD cases occurred after an intercurrent CV event; 110 (16.9%) cases followed heart failure, 28 (4.3%) followed myocardial infarction, 12 (1.84%) followed stroke, and 5 (0.77%) followed multiple CV events. ESRD rate was higher within 30 days in individuals with an intercurrent CV event compared with those without an intercurrent event (HR, 22.2; 95% CI, 17.0-29.0). Compared to no intercurrent CV events, relative risks for ESRD were higher after the occurrence of heart failure overall (HR, 3.4; 95% CI, 2.7-4.2) and at 30 days (HR, 20.1; 95% CI, 14.5-27.9) than after myocardial infarction or stroke (P<0.001). Compared with individuals without pre-ESRD events, those with ESRD following intercurrent CV events were older, were more likely to have prior CV disease, and had higher (24.4 vs 23.1mL/min/1.73m2; P=0.01) baseline estimated glomerular filtration rates (eGFRs) and higher eGFRs at last measurement before ESRD (18.6 vs 15.2mL/min/1.73m2; P<0.001), whereas race, sex, and medication use were similar. Post-ESRD mortality was similar (P=0.3) with and without preceding CV events. CONCLUSIONS: Most ESRD cases occurred in individuals without intercurrent CV events who had lower eGFRs than individuals with intercurrent CV events, but similar post-ESRD mortality. Nevertheless, intercurrent CV events, particularly heart failure, are strongly associated with risk for ESRD. These findings underscore the need for kidney-specific therapies in addition to treatment of CV risk factors to lower ESRD incidence in diabetes.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Charytan DM, Solomon SD, Ivanovich P, et al. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. Am J Kidney Dis. 2017. PMID: 28599901. doi:10.1053/j.ajkd.2017.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。